The data presented support use of MR vaccine at 6 months to protect young infants during measles outbreaks and in settings ...

UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), an oncology company developing ...

Led by a team of distinguished toxicology experts, TriApex was thrilled to take part in this prestigious meeting, engaging in ...

The live vaccine is produced from the strain Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN), an attenuated, non-replicating orthopoxvirus.

Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad brain distribution and liver ...

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 31, 2025 /PRNewswire/ -- Harbour BioMed ('HBM' or the 'Company'; ...

New research findings provide evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain ...

New research findings provide solid evidence that annual COVID-19 vaccine booster doses continue to be advisable for certain ...

CDI Labs Canada Inc., a leading provider of services for proteome-wide antibody profiling and target identification, today ...

Pfizer Inc. announced today that the European Commission (EC) has issued a decision amending the marketing authorization for ABRYSVO®, the company's bivalent respiratory syncytial virus (RSV) ...

Keymed Biosciences Inc. (HKEX: 02162) announced its annual results of 2024, along with a corporate update.  Rapid development of our pipeline products Stapokibart (CM310) (IL-4R? antibody) Three new ...